Health Condition 1: null- Caesarean section
Conditions
Interventions
Intervention1: bupivacaine and fentanyl: Inj. bupivacaine 8mg plus
Inj. fentanyl 12.5 mcg(0.25cc), spinal route
Control Intervention1: bupivacaine and normal saline: Inj.bupivacaine 8mg plus
Inj. norm
Sponsors
Department of Biotechnology North Eastern Cell
AGMC Agartala
Eligibility
Inclusion criteria
Inclusion criteria: The patients posted for elective caesarean section belonging to ASA(American Society of Anaesthesiologists)grade 1 and 2 only
Exclusion criteria
Exclusion criteria: Patient refusal,any contraindication to neuraxial blockade,pregnancy induced hypertension,placenta praevia, abruptio placentae, intrauterine growth restriction, pre-existing fetal distress.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| quality of anaesthesia(onsetof action, muscle relaxation, quality of analgesia) and duration of analgesiaTimepoint: From 0 hours till patient request for first dose of analgesic. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects of intrathecal fentanyl (nausea, vomiting, pruritis, hypotension,bradycardia, respiratory depression)Timepoint: intraoperative and postoperative;Maternal haemodynamics (heart rate, SpO2, NIBP, MAP, respiratory rate). Timepoint: Every two minutes after administration of spinal anaesthesia till the extraction of the newborn and every five minutes till the completion of the surgery, then every 30 minutes till the patient requests for analgesia;Neonatal outcome (Apgar score at one and five minutes after delivery)Timepoint: at one and five minutes after delivery;Rescue dose of analgesicTimepoint: intraoperative and postoperative | — |
Countries
India
Contacts
Public ContactDr Debashis DebRoy
AGMC and GBP Hospital
Outcome results
None listed